i-labs 朗普达一站式光纤光电实验室

i-labs 朗普达一站式光纤光电实验室

登录或注册

English

CNY

搜索历史记录

力合科技山东分公司 Karyopharm's phase 3 SENTRY trial in myelofibrosis met first co-primary endpoint, demonstrating statistically significant improvement in spleen volume reduction. News release. Karyopharm Therapeutics. March 24, 2026 kontrolfreek inferno 10.1016/j.plantsci.2025.112897 which is more correct- The development of sustainable, durable, highly functional substratum-related materials/apparatuses or The development of substratum-related materials/apparatuses that are sustainable, durable, highly functional

你也许会喜欢

1 2 5 3 6

第1-0条，共0件“力合科技山东分公司”产品

排序方式 : 全部